scholarly journals A nonsense nucleotide substitution in the oculocutaneous albinism II gene underlies the original pink-eyed dilution allele (Oca2p) in mice

2015 ◽  
Vol 64 (2) ◽  
pp. 171-179 ◽  
Author(s):  
Haruka SHOJI ◽  
Yukiko KINIWA ◽  
Ryuhei OKUYAMA ◽  
Mu YANG ◽  
Keiichi HIGUCHI ◽  
...  
1994 ◽  
Vol 91 (25) ◽  
pp. 12071-12075 ◽  
Author(s):  
S. Rosemblat ◽  
D. Durham-Pierre ◽  
J. M. Gardner ◽  
Y. Nakatsu ◽  
M. H. Brilliant ◽  
...  

Nature ◽  
1993 ◽  
Vol 361 (6407) ◽  
pp. 72-76 ◽  
Author(s):  
Eugene M. Rinchik ◽  
Scott J. Bultman ◽  
Bernhard Horsthemke ◽  
Seung-Taek Lee ◽  
Kathleen M. Strunk ◽  
...  

2011 ◽  
Vol 42 (S 01) ◽  
Author(s):  
KA Koch ◽  
CB Bussmann

1992 ◽  
Vol 67 (01) ◽  
pp. 063-065 ◽  
Author(s):  
Sherryl A M Taylor ◽  
Jacalyn Duffin ◽  
Cherie Cameron ◽  
Jerome Teitel ◽  
Bernadette Garvey ◽  
...  

SummaryChristmas disease was first reported as a distinct clinical entity in two manuscripts published in 1952 (1, 2). The eponym associated with this disorder, is the surname of the first patient examined in detail and reported by Biggs and colleagues in a paper describing the clinical and laboratory features of seven affected individuals (3). This patient has severe factor IX coagulant deficiency (less than 0.01 units/ml) and no detectable circulating factor IX antigen (less than 0.01 units/ml). Coding sequence and splice junctions of the factor IX gene from this patient have been amplified in vitro through the polymerase chain reaction (PCR). One nucleotide substitution was identified at nucleotide 30,070 where a guanine was replaced by a cytosine. This mutation alters the amino acid encoded at position 206 in the factor IX protein from cysteine to serine. The non conservative nature of this substitution, the absence of this change in more than 200 previously sequenced factor IX genes and the fact that the remainder of the coding region of this gene was normal, all provide strong circumstantial evidence in favour of this change being the causative mutation in this patient. The molecular characterization of this novel mutation in the index case of Christmas disease, contributes to the rapidly expanding body of knowledge pertaining to Christmas disease pathogenesis.


Diabetes ◽  
1988 ◽  
Vol 37 (8) ◽  
pp. 1068-1070 ◽  
Author(s):  
T. Awata ◽  
Y. Iwamoto ◽  
A. Matsuda ◽  
T. Kuzuya

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yuu Asano ◽  
Kensuke Yamashita ◽  
Aoi Hasegawa ◽  
Takanori Ogasawara ◽  
Hoshie Iriki ◽  
...  

AbstractThe powerful genome editing tool Streptococcus pyogenes Cas9 (SpCas9) requires the trinucleotide NGG as a protospacer adjacent motif (PAM). The PAM requirement is limitation for precise genome editing such as single amino-acid substitutions and knock-ins at specific genomic loci since it occurs in narrow editing window. Recently, SpCas9 variants (i.e., xCas9 3.7, SpCas9-NG, and SpRY) were developed that recognise the NG dinucleotide or almost any other PAM sequences in human cell lines. In this study, we evaluated these variants in Dictyostelium discoideum. In the context of targeted mutagenesis at an NG PAM site, we found that SpCas9-NG and SpRY were more efficient than xCas9 3.7. In the context of NA, NT, NG, and NC PAM sites, the editing efficiency of SpRY was approximately 60% at NR (R = A and G) but less than 22% at NY (Y = T and C). We successfully used SpRY to generate knock-ins at specific gene loci using donor DNA flanked by 60 bp homology arms. In addition, we achieved point mutations with efficiencies as high as 97.7%. This work provides tools that will significantly expand the gene loci that can be targeted for knock-out, knock-in, and precise point mutation in D. discoideum.


Sign in / Sign up

Export Citation Format

Share Document